Purple Biotech Ltd. (PPBT) stock
PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.63+0.07 (+4.49%)
Close on Nov 13, 2026Market cap $1.52MP/E 0.0Yield –
Purple Biotech price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Purple Biotech's price to sales ratio was 3.4× on Feb 28, 2022, against 9.2× a year earlier. Over the last 4 years it ranged from 2.9× to 286.6×, with a median of 10.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Feb 28, 2022 | 3.4× | −1.1 |
| 2021 | Dec 31, 2021 | 4.5× | −2.9 |
| 2020 | Dec 31, 2020 | 7.4× | −3.7 |
| 2019 | Dec 31, 2019 | 11.1× | −51.3 |
| 2018 | Dec 31, 2018 | 62.4× | – |
See a number that looks wrong?